{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:05:09Z","timestamp":1777485909761,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03579-1","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T15:00:35Z","timestamp":1721142035000},"page":"770-777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Malignant melanoma in Portuguese adult population: a scoping review of the real-world evidence"],"prefix":"10.1007","volume":"27","author":[{"given":"Emanuel","family":"Gouveia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita Teixeira","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra I.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6185-5083","authenticated-orcid":false,"given":"Ana","family":"G\u00edrio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita","family":"Dion\u00edsio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Moital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"issue":"19","key":"3579_CR1","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.3390\/cancers14194652","volume":"14","author":"J Lopes","year":"2022","unstructured":"Lopes J, Rodrigues CMP. Melanoma management: from epidemiology to treatment and latest advances. Cancers. 2022;14(19):4652.","journal-title":"Cancers"},{"issue":"4","key":"3579_CR2","first-page":"63","volume":"9","author":"K Saginala","year":"2021","unstructured":"Saginala K, Barsouk A, Aluru JS, Rawla P, Barsouk A. Epidemiology of melanoma. Med Sci. 2021;9(4):63.","journal-title":"Med Sci"},{"issue":"1","key":"3579_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD. Cancer statistics, 2020. CA A Cancer J Clinicians. 2020;70(1):7\u201330.","journal-title":"CA A Cancer J Clinicians"},{"issue":"5","key":"3579_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158(5):495\u2013503.","journal-title":"JAMA Dermatol"},{"issue":"23","key":"3579_CR5","doi-asserted-by":"publisher","first-page":"8984","DOI":"10.3390\/ijms21238984","volume":"21","author":"K Eddy","year":"2020","unstructured":"Eddy K, Chen S. Overcoming immune evasion in melanoma. Int J Mol Sci. 2020;21(23):8984.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3579_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/path.5213","volume":"247","author":"R Rabbie","year":"2019","unstructured":"Rabbie R, Ferguson P, Molina-Aguilar C, Adams DJ, Robles-Espinoza CD. Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities. J Pathol. 2019;247(5):539\u201351.","journal-title":"J Pathol"},{"key":"3579_CR7","unstructured":"Global Cancer Observatory: Cancer Tomorrow. Lyon France. International Agency for Research on Cancer; 2020. Accessed 1 Aug 2023."},{"key":"3579_CR8","doi-asserted-by":"crossref","unstructured":"Davey MG, Miller N, McInerney NM. A review of epidemiology and cancer biology of malignant melanoma. Cureus. 2021;13(5):e15087.","DOI":"10.7759\/cureus.15087"},{"key":"3579_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejca.2022.04.018","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment\u2014update 2022. Eur J Cancer. 2022;170:256\u201384.","journal-title":"Eur J Cancer"},{"issue":"3","key":"3579_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/picr.picr_62_21","volume":"12","author":"D Chodankar","year":"2021","unstructured":"Chodankar D. Introduction to real-world evidence studies. Perspect Clin Res. 2021;12(3):171\u20134.","journal-title":"Perspect Clin Res"},{"issue":"9","key":"3579_CR11","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1093\/oncolo\/oyac114","volume":"27","author":"L Azoulay","year":"2022","unstructured":"Azoulay L. Rationale, strengths, and limitations of real-world evidence in oncology: a Canadian review and perspective. Oncologist. 2022;27(9):e731\u20138.","journal-title":"Oncologist"},{"key":"3579_CR12","unstructured":"R Teixeira de Sousa EG, Costa I, Moital I. INVESTIGA\u00c7\u00c3O CLINICA N\u00c3O INTERVENTIVA DE MELANOMA, EM PORTUGAL. REVIS\u00c3O SISTEM\u00c1TICA DE PUBLICA\u00c7\u00d5ES E APRESENTA\u00c7\u00d5ES EM CONGRESSOS. Eposter apresentado no 18 \u00ba CNO 18 a 20 Nov 2021 Trabalho apresentado como ePoster. 2021."},{"key":"3579_CR13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"7","key":"3579_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"3","key":"3579_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.29021\/spdv.69.3.77","volume":"69","author":"J Gomes","year":"2011","unstructured":"Gomes J, Parente J, Ferreira L, Viana I, Vale E. Melanoma maligno associado a nevo melanoc\u00edtico. J Port Soc Dermatol Venereol. 2011;69(3):413\u201320.","journal-title":"J Port Soc Dermatol Venereol"},{"issue":"2","key":"3579_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.29021\/spdv.73.2.369","volume":"73","author":"H Toda-Brito","year":"2015","unstructured":"Toda-Brito H, Rodrigues T, Tavares E, Parente J, Martins C, Ferreira L. Recidiva de melanoma ap\u00f3s t\u00e9cnica do g\u00e2nglio sentinela negativa-estudo retrospectivo. J Port Soc Dermatol Venereol. 2015;73(2):227\u201335.","journal-title":"J Port Soc Dermatol Venereol"},{"issue":"9","key":"3579_CR17","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/jdv.12236","volume":"28","author":"M Arnold","year":"2014","unstructured":"Arnold M, Holterhues C, Hollestein LM, Coebergh JWW, Nijsten T, Pukkala E, et al. Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol JEADV. 2014;28(9):1170\u20138.","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"3579_CR18","unstructured":"Neto A. An\u00e1lise retrospectiva de melanoma maligno cut\u00e2neo prim\u00e1rio no servi\u00e7o de dermatovenereologia do Hospital Sousa Martins: 1995\u20132007. 2008: Covilh\u00e3."},{"key":"3579_CR19","unstructured":"Silva, A.C., A Perfus\u00e3o Regional Hipert\u00e9rmica em doentes com Melanoma maligno nos membros \u2013 estudo de efetividade no Instituto Portugu\u00eas de Oncologia Francisco Gentil - Porto, in Mestrado em Evid\u00eancia e Decis\u00e3o em Sa\u00fade. FMUP: Reposit\u00f3rio Aberto da Universidade do Porto; 2012."},{"issue":"6","key":"3579_CR20","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.abd.2021.05.005","volume":"96","author":"FJ Morgado","year":"2021","unstructured":"Morgado FJ, Soeiro P, Brinca A, Pinho A, Vieira R. Does the pattern of lymphatic drainage influence the risk of nodal recurrence in trunk melanoma patients with negative sentinel lymph node biopsy? An Bras Dermatol. 2021;96(6):693\u2013693.","journal-title":"An Bras Dermatol"},{"key":"3579_CR21","unstructured":"Silva SACd. Estudo epidemiol\u00f3gico da incid\u00eancia e sobreviv\u00eancia do cancro em pacientes da Regi\u00e3o Norte de Portugal e IPO-Porto. 2019. https:\/******\/recippipppt\/bitstream\/1040022\/15510\/3\/DM_Soraia_Silva.pdf. Accessed Aug 2023"},{"key":"3579_CR22","unstructured":"Silva AdS. Impacto do Rastreio Dermatol\u00f3gico no Diagn\u00f3stico Precoce de Cancro da Pele, in Cl\u00ednica Universit\u00e1ria de Dermatologia e Venerologia. Universiade de Lisboa; 2021. https:\/\/repositorio.ul.pt\/handle\/10451\/51475. Accessed Aug 2023"},{"key":"3579_CR23","unstructured":"Vieira RJDC. Oncog\u00e9nese e Progress\u00e3o do Melanoma\u2014An\u00e1lise Mutacional e Estudo Cl\u00ednico Retrospectivo. Universidade de Coimbra; 2013. http:\/\/estudogeral.sib.uc.pt\/. Accessed Aug 2023"},{"key":"3579_CR24","unstructured":"Camacho C, Queiroz NC, Cl\u00e1udia F, Filipa S, Jos\u00e9 C, Leonor C et al. Registo Oncol\u00f3gico na Regi\u00e3o Aut\u00f3noma da Madeira, 2017. 2017: 1\u201377. https:\/\/comum.rcaap.pt\/handle\/10400.26\/29608"},{"key":"3579_CR25","unstructured":"Camacho C, Queiroz NC, Cl\u00e1udia F, Filipa S, Jos\u00e9 C, Leonor C et al. Registo Oncol\u00f3gico na Regi\u00e3o, 2018. 2020. https:\/\/comum.rcaap.pt\/handle\/10400.26\/35625"},{"issue":"2","key":"3579_CR26","first-page":"282","volume":"65","author":"M Ferreira","year":"2007","unstructured":"Ferreira M, et al. An\u00e1lise retrospectiva de melanoma cut\u00e2neo prim\u00e1rio: 1996\u20132006. Trabalhos da Sociedade Portuguesa de Dermatologia e Venereologia. 2007;65(2):282\u201392.","journal-title":"Trabalhos da Sociedade Portuguesa de Dermatologia e Venereologia"},{"key":"3579_CR27","unstructured":"Mareco, V., F. Pina, and M. Jorge. O papel da radioterapia em doentes com melanoma cut\u00e2neo\u2014an\u00e1lise retrospetiva de um servi\u00e7o. in 3\u00ba simp\u00f3sio Melanoma. 2015."},{"issue":"4","key":"3579_CR28","doi-asserted-by":"publisher","first-page":"480","DOI":"10.20344\/amp.5211","volume":"27","author":"J Moreira","year":"2014","unstructured":"Moreira J, Moreira E, Azevedo F, Mota A. Cutaneous malignant melanoma: a retrospective study of seven years (2006\u20132012). Acta Med Port. 2014;27(4):480\u20138.","journal-title":"Acta Med Port"},{"key":"3579_CR29","doi-asserted-by":"crossref","unstructured":"Gorry C, et al. Neoadjuvant treatment for stage III and IV cutaneous melanoma. Cochrane Database Syst Rev. 2023;1(1):CD012974.","DOI":"10.1002\/14651858.CD012974.pub2"},{"key":"3579_CR30","doi-asserted-by":"publisher","first-page":"1025664","DOI":"10.3389\/fonc.2022.1025664","volume":"12","author":"X-L Tan","year":"2022","unstructured":"Tan X-L, Le A, Scherrer E, Tang H, Kiehl N, Han J, et al. Systematic literature review and meta-analysis of clinical outcomes and prognostic factors for melanoma brain metastases. Front Oncol. 2022;12:1025664.","journal-title":"Front Oncol"},{"issue":"3","key":"3579_CR31","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/SCS.0000000000008054","volume":"33","author":"M Nisi","year":"2022","unstructured":"Nisi M, Izzetti R, Gennai S, Pucci A, Lenzi C, Graziani F. Oral mucosal melanoma. J Craniofac Surg. 2022;33(3):830\u20134.","journal-title":"J Craniofac Surg"},{"issue":"5","key":"3579_CR32","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ijrobp.2014.03.042","volume":"90","author":"S Lazarev","year":"2014","unstructured":"Lazarev S, Gupta V, Hu K, Harrison LB, Bakst R. Mucosal melanoma of the head and neck: a systematic review of the literature. Int J Radiat Oncol Biol Phys. 2014;90(5):1108\u201318.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"44","key":"3579_CR33","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.18632\/oncotarget.27077","volume":"10","author":"M Donia","year":"2019","unstructured":"Donia M, Hansen SW, Svane IM. Real-world evidence to guide healthcare policies in oncology. Oncotarget. 2019;10(44):4513\u20135.","journal-title":"Oncotarget"},{"issue":"3","key":"3579_CR34","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1002\/cam4.5058","volume":"12","author":"AM Balinski","year":"2023","unstructured":"Balinski AM, Vasbinder AL. Metastatic melanoma of the heart: retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes. Cancer Med. 2023;12(3):2356\u201367.","journal-title":"Cancer Med"},{"issue":"1","key":"3579_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaad.2014.09.029","volume":"72","author":"JM Bae","year":"2015","unstructured":"Bae JM, Choi YY, Kim DS, Lee JH, Jang HS, Lee JH, et al. Metastatic melanomas of unknown primary show better prognosis than those of known primary: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2015;72(1):59\u201370.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3579_CR36","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/pds.5163","volume":"30","author":"FC Borges","year":"2021","unstructured":"Borges FC, Ramos C, Ramos A, Mendes GP, Murteira R, Soares P, et al. Monitoring real-life utilization of pembrolizumab in advanced melanoma using the Portuguese National Cancer Registry. Pharmacoepidemiol Drug Saf. 2021;30(3):342\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3579_CR37","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jval.2018.09.085","volume":"21","author":"FC Borges","year":"2018","unstructured":"Borges FC, Murteira R, Ramos C, Soares P, Ferreira M, Furtado C, et al. PCN2\u2014effectiveness and safety of pembrolizumab in advanced or metastatic melanoma: preliminary results from real world. Value Health. 2018;21:S15.","journal-title":"Value Health"},{"issue":"3","key":"3579_CR38","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1003a33","volume":"10","author":"AM Forsea","year":"2020","unstructured":"Forsea AM. Melanoma epidemiology and early detection in europe: diversity and disparities. Dermatol Pract Concept. 2020;10(3): e2020033.","journal-title":"Dermatol Pract Concept"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03579-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T16:22:49Z","timestamp":1738254169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03579-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["3579"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03579-1","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"8 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In\u00eas Costa, Ana G\u00edrio and Maria Rita Dion\u00edsio are employees of Novartis. Sandra Aguiar and In\u00eas Moital were employed by Novartis at the time of this work but currently they work in AstraZeneca. Remaining authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"It was a literature review research, no research involving humans or animals was done.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval (Research involving human participants and\/or animals) and Informed consent statement"}}]}}